NYSE$AGL
agilon health inc. · Q3 2023 earnings
Q3 2023 earnings · · Investor relations
Briefing
Reported strong Q3 2023 results with revenue increasing 75% and Medicare Advantage membership increasing 58%.
agilon health reported a strong third quarter with significant growth in revenue and Medicare Advantage membership. The company's decision to sell MDX Hawaii will allow it to focus on its core partner markets. Total revenue increased by 75% to $1.22 billion, and Medicare Advantage membership increased by 58% to 420,300.
- Total members live on the agilon platform increased to 508,000 as of September 30, 2023, including 420,300 Medicare Advantage members and 87,700 ACO REACH beneficiaries.
- Total revenue of $1.22 billion increased 75% during the third quarter 2023, compared to $695 million in the third quarter 2022.
- Gross profit of $30 million in the third quarter 2023, compared to $26 million in the third quarter 2022.
- Medical margin of $108 million increased 42% during the third quarter 2023, compared to $76 million in the third quarter 2022.
Headline financials
Revenue & EPS history
agilon health · Revenue · Quarterly
$1.22B
Revenue by segment
agilon health · $1.15B total across 2 segments · Q2 2023
- Medical Services Revenue$1.15B+71.4%99.8%
- Other Operating Revenue$2.01M+111.4%0.2%
Forward guidance
Agilon health provided outlook for Q4 2023, excluding MDX Hawaii. They expect total revenues between $1,050 million and $1,060 million, medical margin between $55 million and $70 million, and Adjusted EBITDA between -$36 million and -$24 million.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q3 2023
-2.6%
Avg return
Earnings day
-0.0%
Avg return
5 days after
+6.7%
Avg return
30 days after
50%
10 / 20 earnings
Positive
+20.2%
Q4 2025
Best reaction
-36.1%
Q3 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +4.2% | +122.0% | +256.9% | |
| Q4 2025 | +20.2% | +13.4% | -20.8% | |
| Q3 2025 | +5.1% | -9.0% | -9.9% | |
| Q1 2025 | -25.6% | -33.4% | -51.6% | |
| Q4 2024 | -7.4% | -17.9% | +23.7% | |
| Q3 2024 | -36.1% | -35.1% | -24.7% | |
| Q2 2024 | -12.7% | -14.6% | -36.8% | |
| Q1 2024 | +7.5% | +7.5% | +40.8% | |
| Q4 2023 | +3.1% | -2.1% | -1.1% | |
| Q3 2023 | -13.1% | -19.0% | -33.1% | |
| Q2 2023 | +0.7% | +3.7% | -7.9% | |
| Q1 2023 | -3.4% | -6.6% | -18.9% | |
| Q4 2022 | +15.4% | +14.8% | +12.0% | |
| Q3 2022 | -12.7% | -7.9% | -8.6% | |
| Q2 2022 | -3.3% | -0.4% | -20.3% | |
| Q1 2022 | -8.6% | -19.4% | +1.3% | |
| Q4 2021 | +10.6% | +2.4% | +31.7% | |
| Q3 2021 | +2.7% | +3.6% | -9.5% | |
| Q2 2021 | -3.8% | -6.3% | -3.4% | |
| Q1 2021 | +6.3% | +4.0% | +14.0% | |
| Q4 2020 | — | — | — | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — | |
| Q4 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro